COVID-19 vaccine strategies must focus on severe disease and global equity
In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority to
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
A Alagheband Bahrami, A Azargoonjahromi… - Cellular & molecular …, 2022 - Springer
Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Antibody responses are an important part of immunity after Coronavirus Disease 2019
(COVID-19) vaccination. However, antibody trajectories and the associated duration of …
(COVID-19) vaccination. However, antibody trajectories and the associated duration of …
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina
RE Chahla, RH Tomas-Grau, SI Cazorla… - The Lancet Regional …, 2022 - thelancet.com
Summary Background Gam-COVID-Vac (SPUTNIK V) has been granted emergency use
authorization in 70 nations and has been administered to millions worldwide. However …
authorization in 70 nations and has been administered to millions worldwide. However …
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
S Yegorov, I Kadyrova, B Negmetzhanov… - Scientific reports, 2022 - nature.com
Abstract Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv)
vector-based, COVID-19 vaccine now used in> 70 countries. Yet there is a shortage of data …
vector-based, COVID-19 vaccine now used in> 70 countries. Yet there is a shortage of data …
Immunogenicity of COVID‐19 vaccines in patients with diverse health conditions: A comprehensive systematic review
It remains unclear how effective COVID‐19 vaccinations will be in patients with weakened
immunity due to diseases, transplantation, and dialysis. We conducted a systematic review …
immunity due to diseases, transplantation, and dialysis. We conducted a systematic review …
Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo …
R Tang, L Wang, J Zhang, W Fei, R Zhang… - Frontiers in …, 2024 - frontiersin.org
Introduction In light of the public health burden of the COVID-19 pandemic, boosting the
safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional …
safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional …
A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response
The development of the Coronavirus disease 2019 (COVID-19) vaccine is one of the most
important efforts in controlling the pandemic. Serological tests are used to identify highly …
important efforts in controlling the pandemic. Serological tests are used to identify highly …
[HTML][HTML] Lasting SARS-CoV-2 specific IgG antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V
F Claro, D Silva, JAP Bogado, HR Rangel… - International Journal of …, 2022 - Elsevier
Background Scarce information is available regarding the long-term immunogenicity of the
Sputnik V vaccine. Here Sputnik V vaccinated subjects were evaluated 6 months after …
Sputnik V vaccine. Here Sputnik V vaccinated subjects were evaluated 6 months after …
Viral vector and nucleic acid vaccines against COVID-19: A narrative review
After about 2 years since the first detection of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections in Wuhan, China, in December 2019 that resulted in a worldwide …
2 (SARS-CoV-2) infections in Wuhan, China, in December 2019 that resulted in a worldwide …